![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 211/58 | (2006.01) |
(11) | Number of the document | 3325444 |
(13) | Kind of document | T |
(96) | European patent application number | 16745321.6 |
Date of filing the European patent application | 2016-07-19 | |
(97) | Date of publication of the European application | 2018-05-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-07-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/042933 |
Date | 2016-07-19 |
(87) | Number | WO 2017/015272 |
Date | 2017-01-26 |
(30) | Number | Date | Country code |
201562194725 P | 2015-07-20 | US |
(72) |
CARLOS, Marlon , US
TANDEL, Sagun , US
OLSSON, Roger , SE
HILLGREN, Mikael , SE
FLEMING, Matthew, J. , CH
BOUDIER, Andreas, Philipp , CH
WEBER, Beat, T. , CH
|
(73) |
Acadia Pharmaceuticals Inc. ,
12830 El Camino Real, Suite 400, San Diego, CA 92130,
US
|
(54) | METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C |
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C |